These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18594500)

  • 1. Does hyperlipidemia injure the kidney?
    Gröne EF; Gröne HJ
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):424-5. PubMed ID: 18594500
    [No Abstract]   [Full Text] [Related]  

  • 2. Glomerular cells in the progression of human and experimental nephropathies.
    Floege J; Gröne HJ
    Adv Nephrol Necker Hosp; 1997; 27():15-37. PubMed ID: 9408440
    [No Abstract]   [Full Text] [Related]  

  • 3. The glomerular capillary and disease.
    Michael AF; Nevins T; Fish A; Scheinman J
    Aust N Z J Med; 1981; 11(Suppl 1):76-82. PubMed ID: 7020670
    [No Abstract]   [Full Text] [Related]  

  • 4. Notch receptors: a new target in glomerular diseases.
    Mertens PR; Raffetseder U; Rauen T
    Nephrol Dial Transplant; 2008 Sep; 23(9):2743-5. PubMed ID: 18503100
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical factors in progressive renal injury. The role of proteinuria.
    D'Amico G
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):48-52. PubMed ID: 2024673
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of altered lipid metabolism in the progression of renal disease: experimental evidence.
    Keane WF; Kasiske BL; O'Donnell MP; Kim Y
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):38-42. PubMed ID: 2024671
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms for induction of apoptosis and glomerular disease.
    Kashihara N; Sugiyama H; Makino H
    Nephrol Dial Transplant; 1999; 14 Suppl 1():52-4. PubMed ID: 10048451
    [No Abstract]   [Full Text] [Related]  

  • 8. Can glomerulosclerosis be reversed?
    Fogo AB
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):290-1. PubMed ID: 16932443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kidney lesion in liver diseases].
    Tareeva IE; Nikolaev AIu
    Klin Med (Mosk); 1980 May; 58(5):6-13. PubMed ID: 6991807
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipidemia of nephrosis: pathophysiologic role in progressive glomerular disease.
    Diamond JR
    Am J Med; 1989 Nov; 87(5N):25N-29N. PubMed ID: 2486541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The progression of kidney failure].
    Ritz E
    Dtsch Med Wochenschr; 1993 May; 118(18):593-4. PubMed ID: 8495642
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipidemia and the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Am J Clin Nutr; 1988 Jan; 47(1):157-60. PubMed ID: 3276133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell nephropathy.
    Falk RJ; Jennette JC
    Adv Nephrol Necker Hosp; 1994; 23():133-47. PubMed ID: 8154349
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactive oxygen species and progressive glomerular disease.
    Diamond JR
    J Lab Clin Med; 1994 Oct; 124(4):468-9. PubMed ID: 7930869
    [No Abstract]   [Full Text] [Related]  

  • 15. Podocyte biology and response to injury.
    Mundel P; Shankland SJ
    J Am Soc Nephrol; 2002 Dec; 13(12):3005-15. PubMed ID: 12444221
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of low-protein diets on renal disease: are non-haemodynamic factors involved?
    Heidland A; Sebekova K; Ling H
    Nephrol Dial Transplant; 1995; 10(9):1512-4. PubMed ID: 8559454
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of the glomerulus: KI tells the story.
    Ronco P
    Kidney Int; 2020 Jan; 97(1):5-9. PubMed ID: 31901357
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of oxidants in progressive renal injury.
    Nath KA; Fischereder M; Hostetter TH
    Kidney Int Suppl; 1994 Feb; 45():S111-5. PubMed ID: 8158878
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight reduction in massive obesity associated with focal segmental glomerulosclerosis: another evidence for hyperfiltration?
    Lamas S; Sanz A; Ruiz A; Alvárez J; Mejía F; Rodríguez-Puyol D
    Nephron; 1990; 56(2):225-6. PubMed ID: 2243585
    [No Abstract]   [Full Text] [Related]  

  • 20. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level.
    Ronco PM; Alyanakian MA; Mougenot B; Aucouturier P
    J Am Soc Nephrol; 2001 Jul; 12(7):1558-1565. PubMed ID: 11423587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.